New translational research platform launched to study rare cancers
The University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard today announced the launch
Read moreThe University of Texas MD Anderson Cancer Center and the Broad Institute of MIT and Harvard today announced the launch
Read moreA new analysis by a team of researchers led by Dr. David Nerenz of Henry Ford Health System suggests that
Read moreWorking with fruit flies, scientists at Johns Hopkins Medicine say they have identified a new molecular pathway that helps steer
Read moreThe Centers for Disease Control and Prevention (CDC), in collaboration with the National Institutes of Health (NIH), has launched an
Read moreTuberculosis is a serious infectious disease, which is caused by the Mycobacterium tuberculosis, generally it affects the lungs. Tuberculosis is
Read moreCancerous cells exhibit several key differences from healthy cells that help identify them as dangerous. For instance, the pH —
Read moreResearchers from Cleveland Clinic's Florida Research and Innovation Center (FRIC) have identified a potential new target for anti-COVID-19 therapies. Their
Read moreContrary to long-held beliefs, Type I collagen produced by cancer-associated fibroblasts may not promote cancer development but instead plays a
Read moreResearchers have developed a new tool for addressing disseminated intravascular coagulation (DIC) – a blood disorder that proves fatal in
Read moreGliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study
Read more